Regulus Therapeutics Inc.
RGLS
$1.78
$0.063.49%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
4/9/2025
-
IB Times - Economy
4/2/2025
-
GuruFocus
4/2/2025
-
PR Newswire
3/31/2025
-
Simply Wall St
3/28/2025
-
MarketBeat
3/27/2025
-
GuruFocus
3/27/2025
-
Benzinga
3/27/2025
-
PR Newswire
3/22/2025
-
Ticker Report
3/20/2025
-
24/7 Wall St.
3/18/2025
-
MarketBeat
3/18/2025
-
Insider Monkey
3/16/2025
-
Insider Monkey
3/15/2025
-
MarketBeat
3/15/2025
-
TipRanks Financial Blog
3/14/2025
-
MarketBeat
3/13/2025
-
GuruFocus
3/13/2025
-
PR Newswire
3/13/2025
-
MarketBeat
3/4/2025
-
GuruFocus
3/4/2025
-
PR Newswire
3/3/2025
-
MarketBeat
2/27/2025
-
Ticker Report
2/26/2025
-
MarketBeat
2/21/2025
-
Insider Monkey
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, March 13, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
858 202 6300
Address
4224 Campus Point Court
San Diego, CA 92121
San Diego, CA 92121
Country
Year Founded
Business Description
Sector
Regulus Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States...
more
